Mirae Asset Global ETFs Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
60,776
+2,940
+5% +$542K 0.02% 622
2025
Q4
$10.2M Sell
57,836
-79,024
-58% -$12.9M 0.02% 637
2025
Q3
$19.2M Sell
136,860
-2,972
-2% -$402K 0.03% 447
2025
Q2
$17.6M Sell
139,832
-4,761
-3% -$593K 0.03% 422
2025
Q1
$19.8M Buy
144,593
+27,353
+23% +$3.91M 0.04% 397
2024
Q4
$17.9M Sell
117,240
-14,148
-11% -$2.39M 0.04% 405
2024
Q3
$25.5M Buy
131,388
+3,327
+3% +$696K 0.06% 315
2024
Q2
$29.7M Buy
+128,061
New +$27.8M 0.07% 274

Other funds holding BIIB

Mirae Asset Global ETFs Holdings's BIIB Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Biogen (BIIB) stake by 5.1% in Q1 2026, buying an estimated $542K and bringing the position to 60,776 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #622.

Mirae Asset Global ETFs Holdings first reported a position in BIIB in Q2 2024 and has held it in 8 quarters since. The position peaked at $29.7M in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 60,776 shares of Biogen worth $11.1M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 2,940 Biogen shares in Q1 2026, an estimated $542K.
  • Biogen made up 0.02% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #622 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Biogen in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Biogen position peaked at $29.7M in Q2 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.